000 01316 a2200385 4500
005 20250512132822.0
264 0 _c19691202
008 196912s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.1969.tb15885.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRamos-Morales, F
245 0 0 _aInitial experiences with niridazole.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cOct 1969
300 _a670-85 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAnthelmintics
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aElectroencephalography
650 0 4 _aFeces
_xanalysis
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aImidazoles
_xadverse effects
650 0 4 _aMale
650 0 4 _aPlacebos
650 0 4 _aSchistosoma
_xanalysis
650 0 4 _aSchistosomiasis
_xdrug therapy
650 0 4 _aThiazoles
_xadverse effects
700 1 _aCorrea-Coronas, R
700 1 _aDe Jesus, L G
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 160
_gno. 2
_gp. 670-85
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.1969.tb15885.x
_zAvailable from publisher's website
999 _c4901847
_d4901847